Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the same time, however, care gaps remain that must be addressed.

Wearable trackers found that PE patients were more active if they underwent mechanical thrombectomy than if they were just put on anticoagulation therapy alone.

The studies all answer key clinical questions, highlighting a variety of new technologies, drugs and techniques. 

MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.

TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.

Ohio-based Riverain Technologies is now making its FDA-cleared suite of AI tools available through RapidAI’s Rapid Enterprise Platform.

The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.

The ACCESS model is designed help more patients get treated and managed with advanced technologies. In addition to heart failure, improved coverage has been announced for Medicare beneficiaries battling COPD, substance use disorders and nicotine dependence.

The newly approved device is 14% shorter than the previous version and gives clinicians more options when making implant decisions.

XCath Robotics has received the FDA's breakthrough device designation for its Iris surgical robotic system. The device is used to perform remote robotic-assisted mechanical thrombectomy on patients with acute ischemic stroke.

In an update to an early alert from May, the U.S. Food and Drug Administration said an investigation by the device manufacturer concluded the black spots were part of the PVC material used in manufacturing.

As long as the influencer presents with apparent knowledgeability, a polished appearance, medical accoutrements and a caring demeanor, he or she will probably be afforded plenty of leeway to hold forth on all things health and healthcare.